APO Research
Talk to an analyst

APO RESEARCH · REPORT

Regorafenib Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Regorafenib Drugs Industry Growth and Trends Forecast to 2032

2 January 202692 pages

Choose your research edition.

Industry ResearchRegorafenib Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Regorafenib Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Regorafenib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Regorafenib Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Regorafenib Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Regorafenib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Regorafenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Regorafenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Regorafenib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Regorafenib Drugs include Natco, Bayer, Hansoh Pharma, Kelun Pharmaceutical, Qilu Pharmaceutical, Shanghai Acebright Pharmaceuticals, Yangtze River Pharmaceutical, Zhejiang Huayi Pharmaceutical and Chia Tai Tianqing Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Regorafenib Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Regorafenib Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Regorafenib Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Regorafenib Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Regorafenib Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Regorafenib Drugs Market by Company

Natco

Bayer

Hansoh Pharma

Kelun Pharmaceutical

Qilu Pharmaceutical

Shanghai Acebright Pharmaceuticals

Yangtze River Pharmaceutical

Zhejiang Huayi Pharmaceutical

Chia Tai Tianqing Pharmaceutical

Regorafenib Drugs Segment by Type

Original Drug

Generic Drug

Regorafenib Drugs Segment by Application

Metastatic Colorectal Cancer

Gastrointestinal Stromal Tumors

Hepatocellular Carcinoma

Regorafenib Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Regorafenib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Regorafenib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Regorafenib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Regorafenib Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Regorafenib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Original Drug Table 2. Major Company of Generic Drug Table 3. Global Regorafenib Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Regorafenib Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Regorafenib Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Regorafenib Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Regorafenib Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Regorafenib Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Regorafenib Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Regorafenib Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Regorafenib Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Regorafenib Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Regorafenib Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Regorafenib Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Regorafenib Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Regorafenib Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Regorafenib Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Regorafenib Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Regorafenib Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Regorafenib Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Regorafenib Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Regorafenib Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Regorafenib Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Regorafenib Drugs Industry Trends Table 25. Regorafenib Drugs Industry Drivers Table 26. Regorafenib Drugs Industry Opportunities and Challenges Table 27. Regorafenib Drugs Industry Restraints Table 28. Global Regorafenib Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Regorafenib Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Regorafenib Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Regorafenib Drugs Sales Share by Company (2021-2026) Table 32. Global Regorafenib Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Regorafenib Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Regorafenib Drugs Major Company Production Sites and Headquarters Table 35. Global Regorafenib Drugs Company, Product Type & Application Table 36. Global Regorafenib Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Regorafenib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Regorafenib Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Regorafenib Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Regorafenib Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Regorafenib Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Regorafenib Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Regorafenib Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Regorafenib Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Regorafenib Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Regorafenib Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Regorafenib Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Regorafenib Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Regorafenib Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Regorafenib Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Regorafenib Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Regorafenib Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Regorafenib Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Regorafenib Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Regorafenib Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Regorafenib Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Regorafenib Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Regorafenib Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Regorafenib Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Regorafenib Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Regorafenib Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Regorafenib Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Regorafenib Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Regorafenib Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Regorafenib Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Regorafenib Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Regorafenib Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Regorafenib Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Regorafenib Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Natco Company Information Table 72. Natco Business Overview Table 73. Natco Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Natco Regorafenib Drugs Product Portfolio Table 75. Natco Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bayer Regorafenib Drugs Product Portfolio Table 80. Bayer Recent Development Table 81. Hansoh Pharma Company Information Table 82. Hansoh Pharma Business Overview Table 83. Hansoh Pharma Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hansoh Pharma Regorafenib Drugs Product Portfolio Table 85. Hansoh Pharma Recent Development Table 86. Kelun Pharmaceutical Company Information Table 87. Kelun Pharmaceutical Business Overview Table 88. Kelun Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Kelun Pharmaceutical Regorafenib Drugs Product Portfolio Table 90. Kelun Pharmaceutical Recent Development Table 91. Qilu Pharmaceutical Company Information Table 92. Qilu Pharmaceutical Business Overview Table 93. Qilu Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Qilu Pharmaceutical Regorafenib Drugs Product Portfolio Table 95. Qilu Pharmaceutical Recent Development Table 96. Shanghai Acebright Pharmaceuticals Company Information Table 97. Shanghai Acebright Pharmaceuticals Business Overview Table 98. Shanghai Acebright Pharmaceuticals Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Shanghai Acebright Pharmaceuticals Regorafenib Drugs Product Portfolio Table 100. Shanghai Acebright Pharmaceuticals Recent Development Table 101. Yangtze River Pharmaceutical Company Information Table 102. Yangtze River Pharmaceutical Business Overview Table 103. Yangtze River Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Yangtze River Pharmaceutical Regorafenib Drugs Product Portfolio Table 105. Yangtze River Pharmaceutical Recent Development Table 106. Zhejiang Huayi Pharmaceutical Company Information Table 107. Zhejiang Huayi Pharmaceutical Business Overview Table 108. Zhejiang Huayi Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zhejiang Huayi Pharmaceutical Regorafenib Drugs Product Portfolio Table 110. Zhejiang Huayi Pharmaceutical Recent Development Table 111. Chia Tai Tianqing Pharmaceutical Company Information Table 112. Chia Tai Tianqing Pharmaceutical Business Overview Table 113. Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Product Portfolio Table 115. Chia Tai Tianqing Pharmaceutical Recent Development Table 116. North America Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Regorafenib Drugs Sales by Country (2021-2026) & (K Units) Table 118. North America Regorafenib Drugs Sales Market Share by Country (2021-2026) Table 119. North America Regorafenib Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Regorafenib Drugs Sales Market Share Forecast by Country (2027-2032) Table 121. North America Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Regorafenib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Regorafenib Drugs Market Share by Country (2021-2026) Table 124. North America Regorafenib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Regorafenib Drugs Market Share Forecast by Country (2027-2032) Table 126. Europe Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Regorafenib Drugs Sales by Country (2021-2026) & (K Units) Table 128. Europe Regorafenib Drugs Sales Market Share by Country (2021-2026) Table 129. Europe Regorafenib Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Regorafenib Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Regorafenib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Regorafenib Drugs Market Share by Country (2021-2026) Table 134. Europe Regorafenib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Regorafenib Drugs Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Regorafenib Drugs Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Regorafenib Drugs Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Regorafenib Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Regorafenib Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Regorafenib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Regorafenib Drugs Market Share by Country (2021-2026) Table 144. Asia-Pacific Regorafenib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Regorafenib Drugs Market Share Forecast by Country (2027-2032) Table 146. Latin America Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Regorafenib Drugs Sales by Country (2021-2026) & (K Units) Table 148. Latin America Regorafenib Drugs Sales Market Share by Country (2021-2026) Table 149. Latin America Regorafenib Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Regorafenib Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Regorafenib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Regorafenib Drugs Market Share by Country (2021-2026) Table 154. Latin America Regorafenib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Regorafenib Drugs Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Regorafenib Drugs Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Regorafenib Drugs Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Regorafenib Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Regorafenib Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Regorafenib Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Regorafenib Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Regorafenib Drugs Market Share by Country (2021-2026) Table 164. Middle East and Africa Regorafenib Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Regorafenib Drugs Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Regorafenib Drugs Distributors List Table 169. Regorafenib Drugs Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Regorafenib Drugs Image Figure 2. Global Regorafenib Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Regorafenib Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Regorafenib Drugs Sales (2021-2032) & (K Units) Figure 5. Original Drug Image Figure 6. Global Original Drug Sales YoY Growth (2021-2032) & (K Units) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Regorafenib Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Regorafenib Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Regorafenib Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Regorafenib Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Regorafenib Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Regorafenib Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Regorafenib Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Regorafenib Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Regorafenib Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Regorafenib Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Regorafenib Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Regorafenib Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Regorafenib Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Metastatic Colorectal Cancer Image Figure 24. Global Metastatic Colorectal Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Gastrointestinal Stromal Tumors Image Figure 26. Global Gastrointestinal Stromal Tumors Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hepatocellular Carcinoma Image Figure 28. Global Hepatocellular Carcinoma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Regorafenib Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Regorafenib Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Regorafenib Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Regorafenib Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Regorafenib Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Regorafenib Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Regorafenib Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Regorafenib Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Regorafenib Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Regorafenib Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Regorafenib Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Regorafenib Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Regorafenib Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Regorafenib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Regorafenib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Regorafenib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Regorafenib Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Regorafenib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Regorafenib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Regorafenib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Regorafenib Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Regorafenib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Regorafenib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Regorafenib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Regorafenib Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Regorafenib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Regorafenib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Regorafenib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Regorafenib Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Regorafenib Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Regorafenib Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Regorafenib Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Regorafenib Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Regorafenib Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Metastatic Colorectal Cancer
  • Gastrointestinal Stromal Tumors
  • Hepatocellular Carcinoma
Companies covered
  • Natco
  • Bayer
  • Hansoh Pharma
  • Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • Shanghai Acebright Pharmaceuticals
  • Yangtze River Pharmaceutical
  • Zhejiang Huayi Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Regorafenib Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Regorafenib Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Regorafenib Drugs Market by Type
  6. 1.3.1 Original Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Regorafenib Drugs Market Size by Type
  9. 1.4.1 Global Regorafenib Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Regorafenib Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Regorafenib Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Regorafenib Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Regorafenib Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Regorafenib Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Regorafenib Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Regorafenib Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Regorafenib Drugs Industry Trends
  2. 2.2 Regorafenib Drugs Industry Drivers
  3. 2.3 Regorafenib Drugs Industry Opportunities and Challenges
  4. 2.4 Regorafenib Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Regorafenib Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Regorafenib Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Regorafenib Drugs Price (2021-2026)
  4. 3.4 Global Regorafenib Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Regorafenib Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Regorafenib Drugs Company, Product Type & Application
  7. 3.7 Global Regorafenib Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Regorafenib Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Regorafenib Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Regorafenib Drugs Tier 1, Tier 2, and Tier 3
4 Regorafenib Drugs Regional Status and Outlook
  1. 4.1 Global Regorafenib Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Regorafenib Drugs Historic Market Size by Region
  3. 4.2.1 Global Regorafenib Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Regorafenib Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Regorafenib Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Regorafenib Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Regorafenib Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Regorafenib Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Regorafenib Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Regorafenib Drugs by Application
  1. 5.1 Regorafenib Drugs Market by Application
  2. 5.1.1 Metastatic Colorectal Cancer
  3. 5.1.2 Gastrointestinal Stromal Tumors
  4. 5.1.3 Hepatocellular Carcinoma
  5. 5.2 Global Regorafenib Drugs Market Size by Application
  6. 5.2.1 Global Regorafenib Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Regorafenib Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Regorafenib Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Regorafenib Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Regorafenib Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Regorafenib Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Regorafenib Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Regorafenib Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Natco
  2. 6.1.1 Natco Company Information
  3. 6.1.2 Natco Business Overview
  4. 6.1.3 Natco Regorafenib Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Natco Regorafenib Drugs Product Portfolio
  6. 6.1.5 Natco Recent Developments
  7. 6.2 Bayer
  8. 6.2.1 Bayer Company Information
  9. 6.2.2 Bayer Business Overview
  10. 6.2.3 Bayer Regorafenib Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Regorafenib Drugs Product Portfolio
  12. 6.2.5 Bayer Recent Developments
  13. 6.3 Hansoh Pharma
  14. 6.3.1 Hansoh Pharma Company Information
  15. 6.3.2 Hansoh Pharma Business Overview
  16. 6.3.3 Hansoh Pharma Regorafenib Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hansoh Pharma Regorafenib Drugs Product Portfolio
  18. 6.3.5 Hansoh Pharma Recent Developments
  19. 6.4 Kelun Pharmaceutical
  20. 6.4.1 Kelun Pharmaceutical Company Information
  21. 6.4.2 Kelun Pharmaceutical Business Overview
  22. 6.4.3 Kelun Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Kelun Pharmaceutical Regorafenib Drugs Product Portfolio
  24. 6.4.5 Kelun Pharmaceutical Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Regorafenib Drugs Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 Shanghai Acebright Pharmaceuticals
  32. 6.6.1 Shanghai Acebright Pharmaceuticals Company Information
  33. 6.6.2 Shanghai Acebright Pharmaceuticals Business Overview
  34. 6.6.3 Shanghai Acebright Pharmaceuticals Regorafenib Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Shanghai Acebright Pharmaceuticals Regorafenib Drugs Product Portfolio
  36. 6.6.5 Shanghai Acebright Pharmaceuticals Recent Developments
  37. 6.7 Yangtze River Pharmaceutical
  38. 6.7.1 Yangtze River Pharmaceutical Company Information
  39. 6.7.2 Yangtze River Pharmaceutical Business Overview
  40. 6.7.3 Yangtze River Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Yangtze River Pharmaceutical Regorafenib Drugs Product Portfolio
  42. 6.7.5 Yangtze River Pharmaceutical Recent Developments
  43. 6.8 Zhejiang Huayi Pharmaceutical
  44. 6.8.1 Zhejiang Huayi Pharmaceutical Company Information
  45. 6.8.2 Zhejiang Huayi Pharmaceutical Business Overview
  46. 6.8.3 Zhejiang Huayi Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zhejiang Huayi Pharmaceutical Regorafenib Drugs Product Portfolio
  48. 6.8.5 Zhejiang Huayi Pharmaceutical Recent Developments
  49. 6.9 Chia Tai Tianqing Pharmaceutical
  50. 6.9.1 Chia Tai Tianqing Pharmaceutical Company Information
  51. 6.9.2 Chia Tai Tianqing Pharmaceutical Business Overview
  52. 6.9.3 Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Chia Tai Tianqing Pharmaceutical Regorafenib Drugs Product Portfolio
  54. 6.9.5 Chia Tai Tianqing Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Regorafenib Drugs Sales by Country
  2. 7.1.1 North America Regorafenib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Regorafenib Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Regorafenib Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Regorafenib Drugs Market Size by Country
  6. 7.2.1 North America Regorafenib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Regorafenib Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Regorafenib Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Regorafenib Drugs Sales by Country
  2. 8.1.1 Europe Regorafenib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Regorafenib Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Regorafenib Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Regorafenib Drugs Market Size by Country
  6. 8.2.1 Europe Regorafenib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Regorafenib Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Regorafenib Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Regorafenib Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Regorafenib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Regorafenib Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Regorafenib Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Regorafenib Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Regorafenib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Regorafenib Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Regorafenib Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Regorafenib Drugs Sales by Country
  2. 10.1.1 South America Regorafenib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Regorafenib Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Regorafenib Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Regorafenib Drugs Market Size by Country
  6. 10.2.1 South America Regorafenib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Regorafenib Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Regorafenib Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Regorafenib Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Regorafenib Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Regorafenib Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Regorafenib Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Regorafenib Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Regorafenib Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Regorafenib Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Regorafenib Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Regorafenib Drugs Value Chain Analysis
  2. 12.1.1 Regorafenib Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Regorafenib Drugs Production Mode & Process
  7. 12.2 Regorafenib Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Regorafenib Drugs Distributors
  10. 12.2.3 Regorafenib Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst